147 related articles for article (PubMed ID: 22593464)
21. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.
Blay JY; Negrier S; Combaret V; Attali S; Goillot E; Merrouche Y; Mercatello A; Ravault A; Tourani JM; Moskovtchenko JF
Cancer Res; 1992 Jun; 52(12):3317-22. PubMed ID: 1596890
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection.
Maury CP; Teppo AM
Clin Nephrol; 1984 Dec; 22(6):284-92. PubMed ID: 6441659
[TBL] [Abstract][Full Text] [Related]
23. Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 during and after delivery.
Cicarelli LM; Perroni AG; Zugaib M; de Albuquerque PB; Campa A
Mediators Inflamm; 2005 Jun; 2005(2):96-100. PubMed ID: 16030392
[TBL] [Abstract][Full Text] [Related]
24. Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.
Kanoh Y; Abe T; Masuda N; Akahoshi T
Oncol Rep; 2013 Feb; 29(2):469-73. PubMed ID: 23135313
[TBL] [Abstract][Full Text] [Related]
25. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
Mitani Y; Sawada H; Hayakawa H; Aoki K; Ohashi H; Matsumura M; Kuroe K; Shimpo H; Nakano M; Komada Y
Circulation; 2005 Jan; 111(1):38-43. PubMed ID: 15611368
[TBL] [Abstract][Full Text] [Related]
26. The acute phase response in breast carcinoma.
O'Hanlon DM; Lynch J; Cormican M; Given HF
Anticancer Res; 2002; 22(2B):1289-93. PubMed ID: 12168939
[TBL] [Abstract][Full Text] [Related]
27. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
Liang M; Wang L; Hou FF; Liu J; Liu ZQ; Tian JW
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
[TBL] [Abstract][Full Text] [Related]
28. Serum amyloid A in the assessment of early inflammatory arthritis.
Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
[TBL] [Abstract][Full Text] [Related]
29. [Inflammatory reaction and laboratory tests: serum amyloid A (SAA) protein].
Yamada T
Rinsho Byori; 1990 Mar; 38(3):249-54. PubMed ID: 2112209
[TBL] [Abstract][Full Text] [Related]
30. [Serum amyloid A as a useful index of disease activity in polymyalgia rheumatica].
Yamane T; Yamauchi H; Abe N; Torio N; Shimada R; Senba T; Imaizumi Y; Nomura T
Ryumachi; 2003 Jun; 43(3):544-8. PubMed ID: 12910963
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.
Khan N; Cromer CJ; Campa M; Patz EF
Cancer; 2004 Jul; 101(2):379-84. PubMed ID: 15241837
[TBL] [Abstract][Full Text] [Related]
32. [Development of blood examination method of serum amyloid A and LDL complex, and clinical application to prediction of cardiovascular event].
Mashiba S; Ogasawara K; Takeya M; Wada Y; Sahara M; Kojima S; Tabata K; Ueda M; Uchida K; Aizawa T; Kodama T
Rinsho Byori; 2004 Jan; 52(1):67-74. PubMed ID: 14968563
[TBL] [Abstract][Full Text] [Related]
33. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
[TBL] [Abstract][Full Text] [Related]
34. Serum amyloid A, C-reactive protein and remnant-like lipoprotein particle cholesterol in type 2 diabetic patients with coronary heart disease.
Hamano M; Saito M; Eto M; Nishimatsu S; Suda H; Matsuda M; Matsuki M; Yamamoto S; Kaku K
Ann Clin Biochem; 2004 Mar; 41(Pt 2):125-9. PubMed ID: 15025802
[TBL] [Abstract][Full Text] [Related]
35. [Significance of plasma interleukin-6 in the diagnosis of renal cell carcinoma].
Kamemoto H
Hinyokika Kiyo; 1993 Apr; 39(4):301-6. PubMed ID: 8503325
[TBL] [Abstract][Full Text] [Related]
36. Correlations between serum amyloid A protein and C-reactive protein in infectious diseases.
Lannergård A; Larsson A; Kragsbjerg P; Friman G
Scand J Clin Lab Invest; 2003; 63(4):267-72. PubMed ID: 12940634
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk.
Cremona M; Calabrò E; Randi G; De Bortoli M; Mondellini P; Verri C; Sozzi G; Pierotti MA; La Vecchia C; Pastorino U; Bongarzone I
Cancer; 2010 Mar; 116(5):1326-35. PubMed ID: 20087959
[TBL] [Abstract][Full Text] [Related]
38. Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Sasazuki S; Inoue M; Sawada N; Iwasaki M; Shimazu T; Yamaji T; Tsugane S;
Carcinogenesis; 2010 Apr; 31(4):712-8. PubMed ID: 20083644
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
[TBL] [Abstract][Full Text] [Related]
40. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
Johnson TV; Abbasi A; Owen-Smith A; Young A; Ogan K; Pattaras J; Nieh P; Marshall FF; Master VA
J Urol; 2010 Feb; 183(2):480-5. PubMed ID: 20006861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
